Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program

Basit Öğe Kaydı
dc.contributor.authorAladağ, M.
dc.date.accessioned2019-07-25T06:54:23Z
dc.date.available2019-07-25T06:54:23Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.identifier.citationAladağ, M. (2018). Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program. Cilt:68, 301-301 ss.en_US
dc.identifier.endpage301en_US
dc.identifier.startpage301en_US
dc.identifier.urihttps://hdl.handle.net/11616/12931
dc.identifier.volume68en_US
dc.language.isoenen_US
dc.publisherElsevıer scıence bv, po box 211, 1000 ae amsterdam, netherlandsen_US
dc.relation.ispartofJournal of hepatologyen_US
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_US
dc.titleRecurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access programen_US
dc.typeArticleen_US

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Tıp Fakültesi, İç Hastalıkları Anabilim Dalı Koleksiyonu